ZA938791B - Method and pharmaceutical preparations for reducing the activity of cells. - Google Patents

Method and pharmaceutical preparations for reducing the activity of cells.

Info

Publication number: ZA938791B
Authority: ZA; South Africa
Prior art keywords: activity; reducing; cells; cell; pharmaceutical preparations
Prior art date: 1992-11-30

Application number

ZA938791A

Other languages

English (en)

Inventor

Joseph Levy

Yoav Sharoni

Original Assignee

Makhteshim Chem Works Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-30

Filing date

1993-11-24

Publication date

1994-10-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA938791(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-11-24 Application filed by Makhteshim Chem Works Ltd filed Critical Makhteshim Chem Works Ltd

1994-10-03 Publication of ZA938791B publication Critical patent/ZA938791B/xx

Links

230000000694 effects Effects 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 2
JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract 2
229960004999 lycopene Drugs 0.000 abstract 2
235000012661 lycopene Nutrition 0.000 abstract 2
239000001751 lycopene Substances 0.000 abstract 2
ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
230000005907 cancer growth Effects 0.000 abstract 1
230000010261 cell growth Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Nutrition Science (AREA)
Botany (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Physiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA938791A 1992-11-30 1993-11-24 Method and pharmaceutical preparations for reducing the activity of cells. ZA938791B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL10392092A IL103920A (en)	1992-11-30	1992-11-30	Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Publications (1)

Publication Number	Publication Date
ZA938791B true ZA938791B (en)	1994-10-03

Family

ID=11064278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA938791A ZA938791B (en)	1992-11-30	1993-11-24	Method and pharmaceutical preparations for reducing the activity of cells.

Country Status (14)

Country	Link
US (1)	US5827900A (da)
EP (1)	EP0600544B1 (da)
JP (1)	JPH06227970A (da)
KR (1)	KR100301682B1 (da)
CN (1)	CN1142774C (da)
AT (1)	ATE225168T1 (da)
AU (1)	AU679467B2 (da)
CA (1)	CA2109750A1 (da)
DE (1)	DE69332350T2 (da)
DK (1)	DK0600544T3 (da)
ES (1)	ES2181682T3 (da)
IL (1)	IL103920A (da)
MX (1)	MX9307509A (da)
ZA (1)	ZA938791B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262109B1 (en)	1995-12-22	2001-07-17	Henkel Corporation	Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0793491B1 (en) *	1994-12-22	2003-05-02	Henkel Corporation	Pharmaceutical compositions comprising lycopene
JP2750281B2 (ja) *	1995-06-15	1998-05-13	睦憲藤原	高コレステロール血症治療剤
IT1283143B1 (it) *	1996-07-12	1998-04-07	Indena Spa	Metodo di estrazione del licopene ed estratti che lo contengono
US20060160702A1 (en) *	1998-02-23	2006-07-20	Etienne Soudant	Compositions comprising anti-proliferative agents and use thereof
GB9808796D0 (en)	1998-04-24	1998-06-24	Rowett Research Services Limit	Antithrombotic agents
GB9821671D0 (en)	1998-10-05	1998-12-02	Muhlbauer Roman C	Plant extracts for the treatment of increased bone resorption
IL129442A0 (en) *	1999-04-14	2000-02-29	Lycored Natural Prod Ind Ltd	Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
US6399115B2 (en)	1999-09-10	2002-06-04	Glenn Braswell	Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
IL135335A (en) *	2000-03-29	2013-12-31	Lycored Natural Prod Ind Ltd	Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
US6989161B2 (en) *	2000-06-12	2006-01-24	Access Business Group International Llc	Phytonutrient nutritional supplement
IL146449A0 (en) *	2001-11-12	2002-07-25	Lycored Natural Prod Ind Ltd	Method and pharmaceutical preparations for reducing the activity of cells
EP1314438A1 (en) *	2001-11-23	2003-05-28	Nutricia N.V.	Anti-proliferative composition
US20040001898A1 (en) *	2002-06-26	2004-01-01	Armand Malnoe	Compositions and methods for detoxification and cancer prevention
RU2008115148A (ru) *	2005-10-11	2009-11-20	Ликоред Лтд. (Il)	Продукты окисления каротиноидов как химиопредупреждающие и химиотерапевтические агенты
US8569356B2 (en) *	2005-10-25	2013-10-29	University Of Florida Research Foundation, Inc.	Cyclin dependent kinase inhibitors
TW200738227A (en) *	2006-04-03	2007-10-16	Panatoz Corp	One kind of multi-carotenoids and its administration
US8221803B1 (en)	2007-06-25	2012-07-17	OncoNatural Solutions, Inc.	Composition for prostate health
CN101978986A (zh) *	2010-10-21	2011-02-23	蒋科罡	一种治疗肿瘤的中药制剂及制法
CN101961354A (zh) *	2010-10-21	2011-02-02	蒋科罡	一种配用蜂王浆治疗肿瘤的中药及制法
CN102894421A (zh) *	2011-07-24	2013-01-30	江西食方食坊中药食品有限公司	一种预防前列腺疾病的番杞饮料及其制备方法
CN107049998A (zh) *	2016-09-20	2017-08-18	南华大学附属第二医院	番茄红素顺式异构体在制备卵巢癌治疗药物中的应用
IT201700005649A1 (it) *	2017-01-19	2018-07-19	Associazione Oncologica Milanese Amo La Vita Onlus	Uso di derivati di carotenoidi per ridurre la tossicità ed aumentare l’efficacia di trattamenti antitumorali anti-egfr
CN109172552A (zh) *	2018-07-18	2019-01-11	浙江格蕾斯生物科技有限公司	男性前列腺癌植物防治药物及制取方法
KR102220400B1 (ko) *	2019-03-06	2021-02-26	파이룽 머시너리 밀 코., 엘티디.	2개의 노크-오버로 형성된 비트 사이에 조절 가능한 간극을 갖는 횡편기 구조

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1509587A (en) *	1975-08-19	1978-05-04	Ajinomoto Kk	Anti-tumour composition
FR2558372B1 (fr) *	1984-01-25	1987-08-07	Oreal	Composition medicamenteuse pour le traitement de l'acne
US5008295A (en) *	1987-07-30	1991-04-16	Lion Corporation	Method inhibiting the growth of cancer cells
DE69018117T2 (de) *	1989-04-21	1995-10-26	Kirin Brewery	Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
FR2664164A1 (fr) *	1990-07-04	1992-01-10	Texinfine Patrinove	Composition dermatologique ou cosmetique.

1992
- 1992-11-30 IL IL10392092A patent/IL103920A/xx not_active IP Right Cessation
1993
- 1993-11-23 CA CA002109750A patent/CA2109750A1/en not_active Abandoned
- 1993-11-24 ZA ZA938791A patent/ZA938791B/xx unknown
- 1993-11-25 DK DK93203295T patent/DK0600544T3/da active
- 1993-11-25 AT AT93203295T patent/ATE225168T1/de not_active IP Right Cessation
- 1993-11-25 DE DE69332350T patent/DE69332350T2/de not_active Revoked
- 1993-11-25 ES ES93203295T patent/ES2181682T3/es not_active Expired - Lifetime
- 1993-11-25 EP EP93203295A patent/EP0600544B1/en not_active Revoked
- 1993-11-26 JP JP5296934A patent/JPH06227970A/ja active Pending
- 1993-11-27 CN CNB931216370A patent/CN1142774C/zh not_active Expired - Fee Related
- 1993-11-29 MX MX9307509A patent/MX9307509A/es unknown
- 1993-11-29 KR KR1019930025649A patent/KR100301682B1/ko not_active Expired - Lifetime
- 1993-11-29 AU AU52014/93A patent/AU679467B2/en not_active Ceased
1995
- 1995-09-22 US US08/532,263 patent/US5827900A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69332350D1 (de)	2002-11-07
ATE225168T1 (de)	2002-10-15
JPH06227970A (ja)	1994-08-16
EP0600544B1 (en)	2002-10-02
KR100301682B1 (ko)	2001-10-22
AU679467B2 (en)	1997-07-03
EP0600544A1 (en)	1994-06-08
CN1142774C (zh)	2004-03-24
AU5201493A (en)	1994-06-09
US5827900A (en)	1998-10-27
KR940011010A (ko)	1994-06-20
ES2181682T3 (es)	2003-03-01
IL103920A0 (en)	1993-04-04
CN1095589A (zh)	1994-11-30
IL103920A (en)	2000-07-26
CA2109750A1 (en)	1994-05-31
DE69332350T2 (de)	2003-06-18
MX9307509A (es)	1997-06-28
DK0600544T3 (da)	2002-11-18

Publication	Publication Date	Title
IL103920A0 (en)	1993-04-04	Method and pharmaceutical preparations for inhibiting the growth of cancer cells
ZA885192B (en)	1989-04-26	Pharmaceutical preparations
AU4697393A (en)	1994-03-03	Pharmaceutical and/or cosmetic preparation and the use of the preparation
AU5022593A (en)	1994-05-12	Prodrugs, their preparation and use as pharmaceuticals
TW376319B (en)	1999-12-11	Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
NZ236823A (en)	1993-08-26	Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
TW234691B (da)	1994-11-21
AU549481B2 (en)	1986-01-30	Hair growing agent
EP0137543A3 (en)	1987-09-02	Pharmaceutical composition for the therapy of peripheral arteriopathies
ES2194055T3 (es)	2003-11-16	Nuevo uso de prostaglandinas.
AU5938398A (en)	1998-05-21	Pour-on formulations containing polymeric material, glycols and glycerides
HU906721D0 (en)	1991-07-29	Methylene-diphosphonic acid derivatives and inflammation-preventing preparations containing them as active agents
EP0370481A3 (de)	1991-01-16	Pharmazeutische Präparate zur verbesserten Resorption antibakterieller Verbindungen
DE3874610D1 (da)	1992-10-22
AU591046B2 (en)	1989-11-23	Physiologically active agent for agricultural use
RU94040865A (ru)	1996-08-10	Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
HK8994A (en)	1994-02-04	Medicament for treatment of pregnancy-induced hypertension
EP0132772A3 (en)	1987-08-05	Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
CA2100314A1 (en)	1995-01-13	Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers
RU93053031A (ru)	1996-10-10	Способ снижения активности клеток, способ подавления раковых клеток и фармацевтические препараты для снижения активности клеток, способ лечения
AU4629989A (en)	1990-05-28	Anti-inflammatory active ingredients for cosmetic preparations
IT1254256B (it)	1995-09-14	Derivati di idroisochinolina
ITMI921151A1 (it)	1993-11-14	Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione
HUT64689A (en)	1994-02-28	Cosmetic preparations containing medicinal plant extracts as active ingredients